DocWire News Editors

DocwireNews

Social factors contribute to disparities in genetic counseling and testing among men with prostate cancer, according a study published in Urologic Oncology.In a retrospective analysis, the researchers assessed 14,610 patients (72.0% were white; 62.7% were &ge;65 years) diagnosed with prostate cancer from April 2011 to August 2020. All data were obtained from electronic health records, and patient characteristics were collated using genetic counselor visits. The primary endpoint was defined as the receipt of a genetic counseling visit and receipt of genetic testing. A total of 667 patients completed an appointment with a genetic counselor, while 439 patients received germline genetic test results.According to the results, patients aged &ge;65 years (adjusted odds ratio [OR], 0.53; 95% confidence interval [CI], 0.44-0.65) and those who were non-English proficient (adjusted OR, 0.71; 95% CI, 0.42-1.21) were less likely to receive genetic counseling. Overall, the researchers observed that genetic counseling was the strongest independent predictor of receipt of genetic testing.&ldquo;The results of the current study highlight that the role of social factors in contributing to disparities in genetic counseling and testing among men with prostate cancer,&rdquo; the researchers concluded. They added that the results &ldquo;underscore the importance of developing novel strategies to tackle contributors of observed disparities including language, age, and insurance status.&rdquo;

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Hatem Soliman, MD

Using Dendritic Cell Vaccines to Boost Neoadjuvant Therapy in HER2+ Breast Cancer

HER2 Breast Cancer

Kathleen Liu, MD

Joel M. Topf, MD, FACP

AKI Approaches and ASN Kidney Health Guidance

NKF Spring Clinical Meetings 2025

Latest News

How Social Factors Play a Role in Prostate Cancer Disparities

Oncology

Social factors contribute to disparities in genetic counseling and testing among men with prostate cancer, according a study published in Urologic Oncology. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe